The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.
COVID-19 deaths
In-hospital mortality
Risk factors
Journal
Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
17
02
2021
revised:
18
04
2021
accepted:
19
04
2021
pubmed:
7
5
2021
medline:
2
6
2021
entrez:
6
5
2021
Statut:
ppublish
Résumé
The COVID-19-related death rate varies between countries and is affected by various risk factors. This multicenter registry study was designed to evaluate the mortality rate and the related risk factors in Turkey. We retrospectively evaluated 1500 adults with COVID-19 from 26 centers who were hospitalized between March 11 and July 31, 2020. In the study group, 1041 and 459 cases were diagnosed as definite and highly probable cases, respectively. There were 993 PCR-positive cases (66.2%). Among all cases, 1144 (76.3%) were diagnosed with non-severe pneumonia, whereas 212 (14.1%) had severe pneumonia. Death occurred in 67 patients, corresponding to a mortality rate of 4.5% (95% CI:3.5-5.6). The univariate analysis demonstrated that various factors, including male sex, age ≥65 years and the presence of dyspnea or confusion, malignity, chronic obstructive lung disease, interstitial lung disease, immunosuppressive conditions, severe pneumonia, multiorgan dysfunction, and sepsis, were positively associated with mortality. Favipiravir, hydroxychloroquine and azithromycin were not associated with survival. Following multivariate analysis, male sex, severe pneumonia, multiorgan dysfunction, malignancy, sepsis and interstitial lung diseases were found to be independent risk factors for mortality. Among the biomarkers, procalcitonin levels on the 3rd-5th days of admission showed the strongest associations with mortality (OR: 6.18; 1.6-23.93). This study demonstrated that the mortality rate in hospitalized patients in the early phase of the COVID-19 pandemic was a serious threat and that those patients with male sex, severe pneumonia, multiorgan dysfunction, malignancy, sepsis and interstitial lung diseases were at increased risk of mortality; therefore, such patients should be closely monitored.
Identifiants
pubmed: 33957434
pii: S0954-6111(21)00139-6
doi: 10.1016/j.rmed.2021.106433
pmc: PMC8079263
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106433Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
JAMA. 2020 Oct 20;324(15):1504-1505
pubmed: 33044515
Nicotine Tob Res. 2020 Aug 24;22(9):1657-1659
pubmed: 32564072
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Tuberk Toraks. 2020 Dec;68(4):371-378
pubmed: 33448734
BMJ. 2020 May 12;369:m1808
pubmed: 32398230
Turk Thorac J. 2020 Nov;21(6):419-432
pubmed: 33352098
Int J Antimicrob Agents. 2020 Aug;56(2):106051
pubmed: 32534186
Lancet. 2020 Aug 15;396(10249):463-464
pubmed: 32798483
Turk J Med Sci. 2020 Nov 13;51(2):440-447
pubmed: 33185365
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e68-e75
pubmed: 32871002
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet Digit Health. 2020 Oct;2(10):e516-e525
pubmed: 32984797
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175
pubmed: 32615866
PLoS One. 2020 Nov 17;15(11):e0241955
pubmed: 33201896
Open Forum Infect Dis. 2020 Sep 12;7(10):ofaa421
pubmed: 33072814
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Pharmacol Res. 2020 Aug;158:104950
pubmed: 32450344
Am J Emerg Med. 2021 Jul;45:290-296
pubmed: 33041130
J Autoimmun. 2020 Aug;112:102473
pubmed: 32439209
Rev Assoc Med Bras (1992). 2020 Dec;66(12):1679-1684
pubmed: 33331576
Indian J Tuberc. 2020 Dec;67(4S):S167-S172
pubmed: 33308665
Am J Emerg Med. 2021 Aug;46:525-531
pubmed: 33221115
Eur J Intern Med. 2020 Jun;76:97-99
pubmed: 32345526
Ann Rheum Dis. 2016 Mar;75(3):481-9
pubmed: 26865703
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
J Infect Chemother. 2021 Feb;27(2):306-311
pubmed: 33191111
Glob Health J. 2020 Dec;4(4):113-117
pubmed: 33294250
Int J Clin Pract. 2021 Apr;75(4):e13858
pubmed: 33237615
Intern Emerg Med. 2020 Nov;15(8):1485-1499
pubmed: 32970246
J Med Virol. 2020 Jun;92(6):577-583
pubmed: 32162702
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Crit Care Med. 1992 Jun;20(6):864-74
pubmed: 1597042
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
Eur Respir J. 2020 May 7;55(5):
pubmed: 32269088
J Epidemiol Glob Health. 2020 Jun;10(2):115-117
pubmed: 32538025
PLoS One. 2020 Nov 18;15(11):e0241541
pubmed: 33206661